IntegraGen Lands $2.4M Loan for Biomarker Development Program | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French molecular diagnostics company IntegraGen has been awarded a €1.6 million ($2.4 million) interest-free loan from the French government to develop cancer biomarker tools, the company said Wednesday.

IntegraGen will use the loan from OSEO (the French state innovation agency) to partner with the French National Institute of Health and Medical Research (INSERM) to develop biomarker panels for personalized medicine and management of liver and colon cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.